Excessive daytime sleepiness as a predictor of cognitive decline in Parkinson disease
Objective: To compare the change in cognitive performance in Parkinson disease (PD) patients over time based on excessive daytime sleepiness (EDS), and to determine if…Effects of Subthalamic Nucleus Deep Brain Stimulation on Phase Amplitude Coupling in Parkinson’s disease
Objective: To investigate the effects of deep brain stimulation (DBS) on neural activity in patients with Parkinson's disease (PD). Specifically, to assess the effects of…Machine Learning Prediction of Motor Score Reduction following DBS Surgery in PD
Objective: This study investigates several machine learning methods for predicting motor score reduction following DBS surgery in patients with PD using multi-modal feature selection. Background:…Impact of vitamin supplements intake on non-motor fluctuations measured by (NoMoFA) in people living with Parkinson’s disease.
Objective: To determine the impact of vitamins supplements on non-motor fluctuations in people living with Parkinson's disease (PEP). Background: Parkinson's disease (PD) is a neurodegenerative…Why Me Why Not? Understanding the Perception of Research among African Americans with PD
Objective: To recognize the barriers of participating in PD research with qualitative and quantitative data. Background: Women, minorities, and people over 70 years of age…Association between dysphagia and body mass index and his impact on the severity of anxiety in patients with Parkinson Disease
Objective: To describe the relation between dysphagia and body mass index and the increase in anxiety and depression in patients with parkinson’s disease. Background: Parkinson’s…18F-Florzolotau PET imaging of tau pathology in the living brain of patients with corticobasal syndrome
Objective: To analyze the topographical patterns of tau pathology in the living brains of patients with CBS using 18F-Florzolotau PET imaging and to examine whether…Foslevodopa/foscarbidopa in patients with advanced Parkinson’s disease: subgroup analyses from a phase 3, randomized study
Objective: Present the efficacy and safety of 24-hour/day continuous subcutaneous infusion (CSCI) of foslevodopa/foscarbidopa (LDP/CDP) across pre-specified subgroups (age, sex, body mass index [BMI], race,…Complex movement disorder presentations of autoimmune encephalitis – recovery at 4 weeks versus 4 years
Objective: The goal is to learn from different presentations of Autoimmune Encephalitis (AIE) so that we consider the diagnosis more quickly, pursue the work-up judiciously…Autoantibody-negative but probable autoimmune hyperreflexia myoclonus syndrome: a case report
Objective: To report a case of steroid-responsive hyperreflexia myoclonus syndrome. Background: Progressive encephalomyelitis with rigidity and myoclonus (PERM) is a variant of stiff-person syndrome (SPS)…
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- …
- 186
- Next Page »